A Radical Proposal to Preserve Cell and Gene Therapy Innovation
Cell and gene therapies are amazing medical breakthroughs but if we don’t find ways to pay for them, the development pipeline will fail.
William Shrank
Will Shrank is a physician and the CEO and co-founder of Aradigm Health, a public benefit corporation focused on cell and gene therapy access and financing. He previously served as Chief Medical Officer at Humana, Director of Innovation at CMMI, and assistant professor at Harvard Medical School. He has spent his career at the intersection of health policy, payer economics, and clinical innovation.